Results 11 to 20 of about 640,590 (268)

Elevated CEA and CA 19-9 Levels within the Normal Ranges Increase the Likelihood of CRC Recurrence in the Chinese Han Population

Applied Bionics and Biomechanics, 2022
Objective. This study aimed to determine if variations in the expression profiles of CA 19-9 and carcinoembryonic antigen (CEA) within the reference range could serve as possible biomarkers for postoperative CRC recurrence. Method.
Lujia Wang, Guangkai Zhang, Jiafeng Shen, Yujiang Shen, Guojun Cai   +4 more
doaj   +1 more source

The expression of SERPINE1 in colon cancer and its regulatory network and prognostic value

BMC Gastroenterology, 2023
Background Serpin Peptidase Inhibitor 1 (SERPINE1) promotes cancer progression by making it easier for cancer cells to spread to surrounding normal tissue.
Yigang Wang, Jinyan Wang, Jianchao Gao, Mei Ding, Hua Li   +4 more
doaj   +1 more source

Exosome-mediated lncRNA SND1-IT1 from gastric cancer cells enhances malignant transformation of gastric mucosa cells via up-regulating SNAIL1

Journal of Translational Medicine, 2022
Background Gastric cancer (GC), as one of the most common malignancies across the globe, is the fourth leading cause of cancer-related deaths. Though a large body of research has been conducted to develop the therapeutic methods of GC, the survival rate ...
Guohua Jin, Jianguang Zhang, Tingting Cao, Bang Chen, Yu Tian, Yang Shi   +5 more
doaj   +1 more source

Role of K63-linked ubiquitination in cancer

Cell Death Discovery, 2022
Ubiquitination is a critical type of post-translational modifications, of which K63-linked ubiquitination regulates interaction, translocation, and activation of proteins.
Liangzi Cao, Xiaofang Liu, Bowen Zheng, Chengzhong Xing, Jingwei Liu   +4 more
doaj   +1 more source

The effect of adjuvant chemotherapy on survival in node negative colorectal cancer with or without perineural invasion: a systematic review and meta-analysis

Frontiers in Surgery, 2023
PurposeIt was aimed at assessing the benefits of adjuvant chemotherapy (ACT) for patients with node-negative colorectal cancer (CRC) either with or without perineural invasion (PNI).MethodsWe systematically searched PubMed, Cochrane Library, Embase, and ...
Hongan Ying, Jinfan Shao, Nansheng Liao, Xijuan Xu, Wenfeng Yu, Weiwen Hong   +5 more
doaj   +1 more source

LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2

World Journal of Surgical Oncology, 2022
Background Pseudogene-derived long non-coding RNAs (lncRNAs) have been reported to act as key regulatory factors of cancers. However, the study focused on pseudogene misato family member 2 (MSTO2P) in the occurrence and development of colorectal cancer ...
Mengjun Guo, Xiling Zhang
doaj   +1 more source

Expression and regulatory network of E3 ubiquitin ligase NEDD4 family in cancers

BMC Cancer, 2023
NEDD4 family represent an important group of E3 ligases, which regulate various cellular pathways of cell proliferation, cell junction and inflammation.
Liangzi Cao, Hao Li, Xiaofang Liu, Yubang Wang, Bowen Zheng, Chengzhong Xing, Naijin Zhang, Jingwei Liu   +7 more
doaj   +1 more source

Intestine

, 2023
This data is non targeted metabolomics data for the Intestine of C57 mice in the normal group and acute liver failure group.
Ling Xu (17611776)
core   +1 more source

Association between niacin and mortality among patients with cancer in the NHANES retrospective cohort

BMC Cancer, 2022
Background The vitamin niacin is used as a lipid-regulating supplement, but it is unknown whether niacin has a positive influence on cancer prognosis.
Hongan Ying, Lijie Gao, Nansheng Liao, Xijuan Xu, Wenfeng Yu, Weiwen Hong   +5 more
doaj   +1 more source

Herbal extracts modulate the amplitude and frequency of slow waves in circular smooth muscle of mouse small intestine [PDF]

, 2004
Background: Herbal preparations like STW 5 (Iberogast(R)) are widely used drugs in the treatment of dyspepsia and motility-related disorders of the gastrointestinal tract.
Weiser, D., Storr, Martin, Göke, B., Schirra, J., Kelber, O., Sibaev, A., Allescher, H. D.   +6 more
core   +1 more source